The Horseracing Integrity and Safety Authority has released a request for proposals for research into whether furosemide is a performance-enhancing drug in Thoroughbred racehorses. The research is required as part of HISA's Congressional mandate and its conclusions will be used to guide HISA's Furosemide Advisory Committee in its recommendations to the HISA Board on next steps regarding the regulation of furosemide.
Responses to the RFP are due by Oct. 15 at 11:59 p.m. ET. Questions about the RFP and the process for submitting a response may be sent to Dr. Jennifer Durenberger at jennifer.durenberger@hisaus.org and/or Sam Reinhardt at samuel.reinhardt@hisaus.org.
Final proposals may also be submitted via email to Durenberger and Reinhardt.
Not a subscriber? Click here to sign up for the daily PDF or alerts.
